---
layout: default
title: Multi-View MRI Approach for Classification of MGMT Methylation in Glioblastoma Patients
---

# Multi-View MRI Approach for Classification of MGMT Methylation in Glioblastoma Patients

**arXiv**: [2512.14232v1](https://arxiv.org/abs/2512.14232) | [PDF](https://arxiv.org/pdf/2512.14232.pdf)

**ä½œè€…**: Rawan Alyahya, Asrar Alruwayqi, Atheer Alqarni, Asma Alkhaldi, Metab Alkubeyyer, Xin Gao, Mona Alshahrani

**åˆ†ç±»**: cs.CV

**å‘å¸ƒæ—¥æœŸ**: 2025-12-16

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºå¤šè§†å›¾MRIæ–¹æ³•ï¼Œåˆ©ç”¨ç©ºé—´å…³ç³»æ£€æµ‹èƒ¶è´¨æ¯ç»†èƒžç˜¤MGMTç”²åŸºåŒ–çŠ¶æ€ï¼Œé¿å…å¤æ‚3Dæ¨¡åž‹é—®é¢˜ã€‚**

**å…³é”®è¯**: `èƒ¶è´¨æ¯ç»†èƒžç˜¤` `MGMTç”²åŸºåŒ–æ£€æµ‹` `å¤šè§†å›¾MRI` `æ”¾å°„åŸºå› ç»„å­¦` `æ·±åº¦å­¦ä¹ æ¨¡åž‹` `éžä¾µå…¥æ€§è¯Šæ–­` `ç²¾å‡†åŒ»å­¦` `è‚¿ç˜¤åˆ‡ç‰‡æå–`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. æ ¸å¿ƒé—®é¢˜ï¼šçŽ°æœ‰MGMTç”²åŸºåŒ–æ£€æµ‹ä¾èµ–ä¾µå…¥æ€§æ´»æ£€ï¼Œç¼ºä¹é«˜æ•ˆéžä¾µå…¥æ€§æ–¹æ³•ï¼Œä¸”å¤æ‚3Dæ¨¡åž‹å­˜åœ¨å‚æ•°å¤šã€æ”¶æ•›æ…¢ã€å†…å­˜éœ€æ±‚å¤§ç­‰é—®é¢˜ã€‚
2. æ–¹æ³•è¦ç‚¹ï¼šæå‡ºå¤šè§†å›¾MRIæ–¹æ³•ï¼Œåˆ©ç”¨ç©ºé—´å…³ç³»æ•´åˆä¸‰ä¸ªè§†å›¾ä¿¡æ¯ï¼Œé¿å…å¤æ‚3Dæ¨¡åž‹ï¼Œå¹¶å¼•å…¥æ–°è‚¿ç˜¤åˆ‡ç‰‡æå–æŠ€æœ¯æå‡æ€§èƒ½ã€‚
3. å®žéªŒæˆ–æ•ˆæžœï¼šé€šè¿‡å¯¹æ¯”å®žéªŒï¼Œæ–°æ–¹æ³•åœ¨å¤šä¸ªè¯„ä¼°æŒ‡æ ‡ä¸Šä¼˜äºŽçŽ°æœ‰æ–¹æ³•ï¼ŒéªŒè¯äº†å…¶æœ‰æ•ˆæ€§å’Œéžä¾µå…¥æ€§æ£€æµ‹æ½œåŠ›ã€‚

## ðŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

MGMTå¯åŠ¨å­ç”²åŸºåŒ–çš„å­˜åœ¨æ˜¾è‘—å½±å“èƒ¶è´¨æ¯ç»†èƒžç˜¤ï¼ˆGBMï¼‰æ‚£è€…åŒ–ç–—æ•ˆæžœã€‚ç›®å‰ï¼ŒMGMTå¯åŠ¨å­ç”²åŸºåŒ–çš„ç¡®è®¤ä¾èµ–äºŽä¾µå…¥æ€§è„‘è‚¿ç˜¤ç»„ç»‡æ´»æ£€ã€‚æœ¬ç ”ç©¶æŽ¢ç´¢äº†æ”¾å°„åŸºå› ç»„å­¦æŠ€æœ¯ï¼Œè¿™æ˜¯ä¸€ç§åœ¨ç²¾å‡†åŒ»å­¦ä¸­å…·æœ‰å‰æ™¯çš„æ–¹æ³•ï¼Œæ—¨åœ¨ä»ŽåŒ»å­¦å›¾åƒä¸­è¯†åˆ«é—ä¼ æ ‡è®°ã€‚åˆ©ç”¨MRIæ‰«æå’Œæ·±åº¦å­¦ä¹ æ¨¡åž‹ï¼Œæˆ‘ä»¬æå‡ºäº†ä¸€ç§æ–°çš„å¤šè§†å›¾æ–¹æ³•ï¼Œè€ƒè™‘MRIè§†å›¾ä¹‹é—´çš„ç©ºé—´å…³ç³»æ¥æ£€æµ‹MGMTç”²åŸºåŒ–çŠ¶æ€ã€‚é‡è¦çš„æ˜¯ï¼Œæˆ‘ä»¬çš„æ–¹æ³•ä»Žæ‰€æœ‰ä¸‰ä¸ªè§†å›¾ä¸­æå–ä¿¡æ¯ï¼Œè€Œä¸ä½¿ç”¨å¤æ‚çš„3Dæ·±åº¦å­¦ä¹ æ¨¡åž‹ï¼Œé¿å…äº†é«˜å‚æ•°æ•°é‡ã€æ”¶æ•›ç¼“æ…¢å’Œå¤§é‡å†…å­˜éœ€æ±‚ç­‰é—®é¢˜ã€‚æˆ‘ä»¬è¿˜å¼•å…¥äº†ä¸€ç§æ–°çš„è‚¿ç˜¤åˆ‡ç‰‡æå–æŠ€æœ¯ï¼Œå¹¶åŸºäºŽå¤šä¸ªè¯„ä¼°æŒ‡æ ‡å±•ç¤ºäº†å…¶ä¼˜äºŽçŽ°æœ‰æ–¹æ³•çš„ä¼˜åŠ¿ã€‚é€šè¿‡å°†æˆ‘ä»¬çš„æ–¹æ³•ä¸Žæœ€å…ˆè¿›çš„æ¨¡åž‹è¿›è¡Œæ¯”è¾ƒï¼Œæˆ‘ä»¬è¯æ˜Žäº†è¯¥æ–¹æ³•çš„æœ‰æ•ˆæ€§ã€‚æ­¤å¤–ï¼Œæˆ‘ä»¬åˆ†äº«äº†å·²å‘è¡¨æ¨¡åž‹çš„å¯é‡å¤æµç¨‹ï¼Œé¼“åŠ±é€æ˜Žåº¦å’Œç¨³å¥è¯Šæ–­å·¥å…·çš„å¼€å‘ã€‚æˆ‘ä»¬çš„ç ”ç©¶çªå‡ºäº†éžä¾µå…¥æ€§æ–¹æ³•è¯†åˆ«MGMTå¯åŠ¨å­ç”²åŸºåŒ–çš„æ½œåŠ›ï¼Œå¹¶æœ‰åŠ©äºŽæŽ¨è¿›GBMæ²»ç–—ä¸­çš„ç²¾å‡†åŒ»å­¦ã€‚

## ðŸ”¬ æ–¹æ³•è¯¦è§£

æ•´ä½“æ¡†æž¶åŸºäºŽå¤šè§†å›¾MRIå’Œæ·±åº¦å­¦ä¹ æ¨¡åž‹ï¼Œæ ¸å¿ƒæ€æƒ³æ˜¯é€šè¿‡æ•´åˆè½´å‘ã€å† çŠ¶å’ŒçŸ¢çŠ¶ä¸‰ä¸ªMRIè§†å›¾çš„ç©ºé—´å…³ç³»æ¥æ£€æµ‹MGMTç”²åŸºåŒ–çŠ¶æ€ã€‚å…³é”®æŠ€æœ¯åˆ›æ–°ç‚¹åŒ…æ‹¬ï¼šé‡‡ç”¨å¤šè§†å›¾æ–¹æ³•è€Œéžå¤æ‚3Dæ¨¡åž‹ï¼Œé¿å…äº†é«˜å‚æ•°å’Œå†…å­˜é—®é¢˜ï¼›å¼•å…¥æ–°çš„è‚¿ç˜¤åˆ‡ç‰‡æå–æŠ€æœ¯ï¼Œä¼˜åŒ–äº†å›¾åƒé¢„å¤„ç†æ­¥éª¤ã€‚ä¸ŽçŽ°æœ‰æ–¹æ³•çš„ä¸»è¦åŒºåˆ«åœ¨äºŽï¼Œè¯¥æ–¹æ³•ä¸ä¾èµ–3Då·ç§¯ç¥žç»ç½‘ç»œï¼Œè€Œæ˜¯é€šè¿‡å¤šè§†å›¾èžåˆæ•æ‰ç©ºé—´ä¿¡æ¯ï¼Œä»Žè€Œåœ¨ä¿æŒæ€§èƒ½çš„åŒæ—¶é™ä½Žäº†è®¡ç®—å¤æ‚åº¦ï¼Œæé«˜äº†å®žç”¨æ€§å’Œå¯æ‰©å±•æ€§ã€‚

## ðŸ“Š å®žéªŒäº®ç‚¹

æœ€é‡è¦çš„å®žéªŒç»“æžœï¼šæ–°æ–¹æ³•åœ¨å¤šä¸ªè¯„ä¼°æŒ‡æ ‡ä¸Šä¼˜äºŽçŽ°æœ‰æœ€å…ˆè¿›æ¨¡åž‹ï¼ŒéªŒè¯äº†å¤šè§†å›¾æ–¹æ³•çš„æœ‰æ•ˆæ€§ï¼›æ–°è‚¿ç˜¤åˆ‡ç‰‡æå–æŠ€æœ¯æ˜¾è‘—æå‡äº†æ€§èƒ½ï¼Œå±•ç¤ºäº†æŠ€æœ¯ä¼˜åŠ¿ï¼›æ•´ä½“æ–¹æ³•é¿å…äº†3Dæ¨¡åž‹çš„å¤æ‚æ€§é—®é¢˜ï¼Œå®žçŽ°äº†é«˜æ•ˆä¸”ç¨³å¥çš„MGMTç”²åŸºåŒ–çŠ¶æ€æ£€æµ‹ã€‚

## ðŸŽ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶ä¸»è¦åº”ç”¨äºŽèƒ¶è´¨æ¯ç»†èƒžç˜¤çš„ç²¾å‡†åŒ»ç–—é¢†åŸŸï¼Œæ½œåœ¨ä»·å€¼åŒ…æ‹¬ï¼šä¸ºéžä¾µå…¥æ€§MGMTç”²åŸºåŒ–æ£€æµ‹æä¾›æ–°å·¥å…·ï¼Œè¾…åŠ©åŒ–ç–—æ–¹æ¡ˆåˆ¶å®šï¼›æŽ¨åŠ¨æ”¾å°„åŸºå› ç»„å­¦åœ¨ä¸´åºŠè¯Šæ–­ä¸­çš„åº”ç”¨ï¼Œå‡å°‘æ‚£è€…ä¾µå…¥æ€§æ´»æ£€é£Žé™©ï¼›ä¿ƒè¿›é€æ˜Žå’Œå¯é‡å¤çš„AIè¯Šæ–­æµç¨‹å¼€å‘ï¼Œæå‡åŒ»ç–—AIçš„å¯é æ€§å’Œæ™®åŠæ€§ã€‚

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> The presence of MGMT promoter methylation significantly affects how well chemotherapy works for patients with Glioblastoma Multiforme (GBM). Currently, confirmation of MGMT promoter methylation relies on invasive brain tumor tissue biopsies. In this study, we explore radiogenomics techniques, a promising approach in precision medicine, to identify genetic markers from medical images. Using MRI scans and deep learning models, we propose a new multi-view approach that considers spatial relationships between MRI views to detect MGMT methylation status. Importantly, our method extracts information from all three views without using a complicated 3D deep learning model, avoiding issues associated with high parameter count, slow convergence, and substantial memory demands. We also introduce a new technique for tumor slice extraction and show its superiority over existing methods based on multiple evaluation metrics. By comparing our approach to state-of-the-art models, we demonstrate the efficacy of our method. Furthermore, we share a reproducible pipeline of published models, encouraging transparency and the development of robust diagnostic tools. Our study highlights the potential of non-invasive methods for identifying MGMT promoter methylation and contributes to advancing precision medicine in GBM treatment.

